These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 7530599)
1. p53 abnormalities and genomic instability in primary human breast carcinomas. Eyfjörd JE; Thorlacius S; Steinarsdottir M; Valgardsdottir R; Ogmundsdottir HM; Anamthawat-Jonsson K Cancer Res; 1995 Feb; 55(3):646-51. PubMed ID: 7530599 [TBL] [Abstract][Full Text] [Related]
2. Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas. Smith CA; Pollice AA; Gu LP; Brown KA; Singh SG; Janocko LE; Johnson R; Julian T; Hyams D; Wolmark N; Sweeney L; Silverman JF; Shackney SE Clin Cancer Res; 2000 Jan; 6(1):112-26. PubMed ID: 10656439 [TBL] [Abstract][Full Text] [Related]
3. Relationship between abnormal p53 protein and failure to express p21 protein in human breast carcinomas. Bukholm IK; Nesland JM; Kåresen R; Jacobsen U; Børresen AL J Pathol; 1997 Feb; 181(2):140-5. PubMed ID: 9120716 [TBL] [Abstract][Full Text] [Related]
4. Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. Bartek J; Iggo R; Gannon J; Lane DP Oncogene; 1990 Jun; 5(6):893-9. PubMed ID: 1694291 [TBL] [Abstract][Full Text] [Related]
5. Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas. Varley JM; Brammar WJ; Lane DP; Swallow JE; Dolan C; Walker RA Oncogene; 1991 Mar; 6(3):413-21. PubMed ID: 2011397 [TBL] [Abstract][Full Text] [Related]
6. Heterogeneous gene alterations in primary breast cancer contribute to discordance between primary and asynchronous metastatic/recurrent sites: HER2 gene amplification and p53 mutation. Sekido Y; Umemura S; Takekoshi S; Suzuki Y; Tokuda Y; Tajima T; Osamura RY Int J Oncol; 2003 Jun; 22(6):1225-32. PubMed ID: 12738987 [TBL] [Abstract][Full Text] [Related]
7. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation. Leung SY; Yuen ST; Chan TL; Chan AS; Ho JW; Kwan K; Fan YW; Hung KN; Chung LP; Wyllie AH Oncogene; 2000 Aug; 19(35):4079-83. PubMed ID: 10962567 [TBL] [Abstract][Full Text] [Related]
8. p53 mutations and histological type of invasive breast carcinoma. Marchetti A; Buttitta F; Pellegrini S; Campani D; Diella F; Cecchetti D; Callahan R; Bistocchi M Cancer Res; 1993 Oct; 53(19):4665-9. PubMed ID: 8402644 [TBL] [Abstract][Full Text] [Related]
9. MYC amplification and TERT expression in breast tumor progression. Bodvarsdóttir SK; Steinarsdóttir M; Hilmarsdóttir H; Jónasson JG; Eyfjörd JE Cancer Genet Cytogenet; 2007 Jul; 176(2):93-9. PubMed ID: 17656250 [TBL] [Abstract][Full Text] [Related]
10. Expression of p53 gene in 184 unifocal hepatocellular carcinomas: association with tumor growth and invasiveness. Hsu HC; Tseng HJ; Lai PL; Lee PH; Peng SY Cancer Res; 1993 Oct; 53(19):4691-4. PubMed ID: 8402647 [TBL] [Abstract][Full Text] [Related]
11. Abnormal expression of cell cycle regulatory proteins in ductal and lobular carcinomas of the breast. Geradts J; Ingram CD Mod Pathol; 2000 Sep; 13(9):945-53. PubMed ID: 11007034 [TBL] [Abstract][Full Text] [Related]
12. Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor. Thorlacius S; Börresen AL; Eyfjörd JE Cancer Res; 1993 Apr; 53(7):1637-41. PubMed ID: 8453635 [TBL] [Abstract][Full Text] [Related]
13. Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines. Wasielewski M; Elstrodt F; Klijn JG; Berns EM; Schutte M Breast Cancer Res Treat; 2006 Sep; 99(1):97-101. PubMed ID: 16541312 [TBL] [Abstract][Full Text] [Related]
14. Allelic loss at BRCA1, BRCA2, and adjacent loci in relation to TP53 abnormality in breast cancer. Tseng SL; Yu IC; Yue CT; Chang SF; Chang TM; Wu CW; Shen CY Genes Chromosomes Cancer; 1997 Dec; 20(4):377-82. PubMed ID: 9408754 [TBL] [Abstract][Full Text] [Related]
16. p53 Gene alterations and p53 protein accumulation in infiltrating ductal breast carcinomas: correlation between immunohistochemical and molecular biology techniques. Hurlimann J; Chaubert P; Benhattar J Mod Pathol; 1994 May; 7(4):423-8. PubMed ID: 8066070 [TBL] [Abstract][Full Text] [Related]
17. p53 Alteration and chromosomal instability in prostatic high-grade intraepithelial neoplasia and concurrent carcinoma: analysis by immunohistochemistry, interphase in situ hybridization, and sequencing of laser-captured microdissected specimens. Al-Maghrabi J; Vorobyova L; Chapman W; Jewett M; Zielenska M; Squire JA Mod Pathol; 2001 Dec; 14(12):1252-62. PubMed ID: 11743048 [TBL] [Abstract][Full Text] [Related]
18. Genetic analysis of DNA microsatellite loci in salivary gland tumours: comparison with immunohistochemical detection of hMSH2 and p53 proteins. Ohki K; Kumamoto H; Ichinohasama R; Suzuki M; Yamaguchi T; Echigo S; Motegi K; Ooya K Int J Oral Maxillofac Surg; 2001 Dec; 30(6):538-44. PubMed ID: 11829237 [TBL] [Abstract][Full Text] [Related]
19. p53 gene mutation in relation to p53 protein accumulation in male and female breast cancer. Nayak BK; Baral RN; Das BR Neoplasma; 1996; 43(5):305-10. PubMed ID: 8996549 [TBL] [Abstract][Full Text] [Related]
20. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer. Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]